Using Click Chemistry To Drug ‘Undruggable’ Tumor Suppressors November 7, 2025 Qinheng Zheng uses a daring approach to reveal new treatments for cancer
HMS Announces Blavatnik Institute Early Career Investigator Awards November 6, 2025 10 projects receive basic and translational research funding
HMS Scientists Win Funding From Blavatnik Biomedical Accelerator September 25, 2025 New technologies take aim at urgent challenges from autoimmune disease to cancer
In Hard-To-Treat Form of Tuberculosis, Shorter, Gentler Therapy Shows Unequal Benefit July 16, 2025 Study suggests treatment should be tailored for disease severity
Study Finds Three New Safe, Effective Ways To Treat Drug-Resistant Tuberculosis January 29, 2025 New options make care faster, safer, and more accessible
How to Realize the Immense Promise of Gene Editing April 17, 2024 Nobel-winning CRISPR scientist emphasizes need for more equitable treatment access
Paving the Way for a New Class of Antibiotics March 5, 2024 Flaws in superbugs’ armor could be exploited to combat antibiotic resistance
What Will It Take to End Tuberculosis? February 15, 2024 A boundary-pushing global collaboration is betting on the power of science
